U.S. markets open in 5 hours 35 minutes
  • S&P Futures

    3,920.25
    -2.25 (-0.06%)
     
  • Dow Futures

    31,962.00
    +46.00 (+0.14%)
     
  • Nasdaq Futures

    13,238.00
    -64.00 (-0.48%)
     
  • Russell 2000 Futures

    2,296.60
    +11.50 (+0.50%)
     
  • Crude Oil

    63.66
    +0.44 (+0.70%)
     
  • Gold

    1,788.20
    -9.70 (-0.54%)
     
  • Silver

    27.95
    +0.03 (+0.10%)
     
  • EUR/USD

    1.2209
    +0.0040 (+0.33%)
     
  • 10-Yr Bond

    1.3890
    0.0000 (0.00%)
     
  • Vix

    21.83
    -1.28 (-5.54%)
     
  • GBP/USD

    1.4150
    +0.0009 (+0.06%)
     
  • USD/JPY

    106.1000
    +0.2180 (+0.21%)
     
  • BTC-USD

    50,079.45
    -178.62 (-0.36%)
     
  • CMC Crypto 200

    999.19
    +4.53 (+0.45%)
     
  • FTSE 100

    6,683.08
    +24.11 (+0.36%)
     
  • Nikkei 225

    30,168.27
    +496.57 (+1.67%)
     

Baxter Germany to start production of BioNTech/Pfizer vaccine by early March

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

BERLIN, Jan 13 (Reuters) - Baxter plans to start production of the COVID-19 vaccine by BioNTech and Pfizer in Germany in late February or early March, Juergen Fleischer, personnel chief at Baxter Germany, said.

"We are still in the process of converting the production facility for the demands of BioNTech's deep-frozen product," he said.

The company will also make vaccines for Novavax at the site, Baxter had announced on Monday.

(Reporting by Andreas Rinke; Writing by Maria Sheahan, editing by Kirsti Knolle)